Chronic Urticaria
43
1
2
30
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.0%
3 terminated out of 43 trials
90.9%
+4.4% vs benchmark
26%
11 trials in Phase 3/4
33%
10 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (43)
A Single-Arm Exploratory Study of NatureU Histra Dissolve on Chronic Urticaria Symptoms
Modified Xiao-Feng Powder for Chronic Urticaria
Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria
A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in China
Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Treatment Options for Chronic Urticaria
A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
Antiplatelet Therapy in Chronic Urticaria
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children
Positive Psychotherapy-Based Counseling (PPT)
Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria.
Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
Real Life Use of Omalizumab in Chronic Urticaria
Safety Study of Levocetirizine and Fexofenadine
Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire
A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)
Dietary Treatment for Chronic Urticaria